Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;37(5):278-81.

Fidaxomicin (Dificid), a Novel Oral Macrocyclic Antibacterial Agent For the Treatment of Clostridium difficile-Associated Diarrhea in Adults

Martin Paspe Cruz

Fidaxomicin (Dificid), a Novel Oral Macrocyclic Antibacterial Agent For the Treatment of Clostridium difficile-Associated Diarrhea in Adults

Martin Paspe Cruz. P T. 2012 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structural formula of fidaxomicin. (From Dificid prescribing information.17)
See this image and copyright information in PMC

References

    1. Drekonja DM, Butler M, MacDonald R, et al. Comparative ef fectiveness of Clostridium difficile treatments: A systematic review. Ann Intern Med. 2011;155:839–847. - PubMed
    1. Gerding DDN, Johnson S, Peterson LR, et al. Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16:459–477. - PubMed
    1. Reinke CM, Messick CR. Update on Clostridium difficile–induced colitis (parts 1 and 2) Am J Hosp Pharm. 1994;51:1771–1781. 1892–1901. - PubMed
    1. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile–associated diarrhea and colitis. Am J Gastroenterol. 1997;92:739–750. - PubMed
    1. American Society of Health-System Pharmacists Pharmacy News. Fidaxomicin approved for C. difficile infections. May 31, 2011. Available at: www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?id=3549. Accessed February 29, 2012. - PubMed

LinkOut - more resources